Medinova Diagnostic Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve Meeting of the ....
Awaiting price reaction for this filing.
Medinova Diagnostic Services has informed BSE that its Board of Directors will meet on Monday, November 3, 2025. The key agenda is to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025. The meeting will also take up other corporate matters as needed. The company has confirmed that the trading window for designated persons and their immediate relatives is already closed since October 1, 2025, and will remain closed until 48 hours after the results are announced, i.e., up to November 5, 2025. The intimation is filed under Regulation 29(1) of the SEBI Listing Regulations.
This is a routine regulatory filing and carries no immediate impact on shareholders. Investors should watch for the Q2/H1 FY26 results on November 3, 2025, which will provide the next set of performance numbers for the company.